The FDA announced on June 2, 2026, that ANI Pharmaceuticals is recalling hydrOXYzine Hydrochloride Oral Solution due to the presence of a foreign substance. The agency issued recall number D-0619-2026 for the nationwide distribution of the drug.
How to tell if you have it
- Brand: ANI Pharmaceuticals
- Product: hydrOXYzine Hydrochloride Oral Solution, USP, 10 mg/5 mL, 473 mL (1 Pint)
- NDC: 70954-912-10
- Lot code: S25133A
- Quantity: 6564 bottles
The hazard
The recall is due to the presence of a foreign substance in the hydrOXYzine Hydrochloride Oral Solution. The FDA classified this as a Class III recall.
Context
ANI Pharmaceuticals has three other recalls on record since October 9, 2020, including a May 12, 2026, recall of Estradiol Gel due to defective containers and a February 15, 2022, recall of Alprazolam Tablets for manufacturing deviations. Other recent recalls of similar products include Graviti Furosemide Tablets Recall (January 10, 2026), Taro Recalls Children's Ibuprofen (March 2, 2026), and Lupin prednisolone acetate ophthalmic suspension recall (June 4, 2026).